November 5, 2009 – The Moscow Arbitration Court considered the disputes between Merck and Russian PTO (Teva Corp. represented by Sojuzpatent is interested party on the side of the Russian PTO) on previous invalidation of Eurasian patent 4544 (related to Alendronate) in favor of Teva Corp.

15 December 2009